Form 4: Amgen EVP, Operations, Esteban Santos, Reports Stock Transaction
SEC Form 4 Filing
Esteban Santos, EVP of Operations at Amgen, reports the disposition of 3,393 shares of common stock to cover tax obligations related to vested restricted stock units.
Summary
- On March 17, 2025, Esteban Santos, EVP of Operations at Amgen, reported a transaction involving Amgen's common stock.
- Santos disposed of 3,393 shares at a price of $313.71 per share.
- This transaction was related to covering tax obligations associated with vested restricted stock units.
- Following the transaction, Santos directly owns 75,075 shares of Amgen common stock.
- Santos also indirectly owns 882.4151 shares through the company's 401(k) plan.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a routine stock transaction by a company executive. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This filing indicates that an executive exercised stock options or had restricted stock units vest, and then sold a portion of the shares to cover the resulting tax obligations. This is a common practice and doesn't necessarily reflect a change in the executive's long-term outlook for the company.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units (RSUs) as a way to align management's interests with those of shareholders.
- The sale of shares to cover tax obligations upon vesting of RSUs is a standard practice across publicly traded companies.
- Comparing Santos's holdings and transactions to those of executives at similar biotech companies like Gilead Sciences, Biogen, and Regeneron would provide a broader context for assessing the significance of this filing.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of the stock transaction and filing date of the Form 4. |
Keywords
Form 4, Amgen, Stock Transaction, Insider Trading, Beneficial Ownership, Esteban Santos, EVP Operations, AMGN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.